Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released May 8, 2023, after the close
10-Q filed May 8, 2023, 38 days after period end · 0000950170-23-018839
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$23.95M | -$23.16M | -$16.51M | -$8.87M |
| EPS Diluted | -$0.53 | -$0.59 | -$0.45 | -$4.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR